US Patent

US8680136 — Cyclic boronic acid ester derivatives and therapeutic uses thereof

Composition of Matter · Assigned to Rempex Pharmaceuticals Inc · Expires 2031-08-29 · 5y remaining

Vulnerability score 10/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects cyclic boronic acid ester derivatives and their use as therapeutic agents, including as antimicrobial compounds and pharmaceutical compositions.

USPTO Abstract

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to 1 cyclic boronic acid ester derivatives and their use as therapeutic agents.

Drugs covered by this patent

Patent Metadata

Patent number
US8680136
Jurisdiction
US
Classification
Composition of Matter
Expires
2031-08-29
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Rempex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.